BiotechTube

Sporanox + Lozanoc

ApprovedCompleted
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Neutropenia

Conditions

Neutropenia

Trial Timeline

Nov 1, 2015 → Dec 1, 2016

NCT ID
NCT02621905

About Sporanox + Lozanoc

Sporanox + Lozanoc is a approved stage product being developed by Mayne Pharma Group for Neutropenia. The current trial status is completed. This product is registered under clinical trial identifier NCT02621905. Target conditions include Neutropenia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02621905ApprovedCompleted

Competing Products

20 competing products in Neutropenia

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaApproved
85
pegfilgrastimKyowa KirinPhase 2
52
HHPG-19K InjectionJiangsu Hengrui MedicinePhase 3
77
caspofungin acetate + Comparator: AmBisomeMerckPhase 2
52
Imipenem + ImipenemMerckApproved
85
Posaconazole IV solution + Posaconazole powder for oral suspensionMerckPhase 1
33
Ceftolozane-Tazobactam + MeropenemMerckApproved
85
Ceftolozane-tazobactam IVMerckApproved
85
Daptomycin + DaptomycinMerckPhase 3
77
pegfilgrastimAmgenPhase 3
76
Neulasta (pegfilgrastim)AmgenApproved
84
Liposomal amphotericin B (AmBisome®) + Liposomal amphotericin B (AmBisome®)Gilead SciencesApproved
84
Filgrastim Hospira (US) + US-approved Neupogen®PfizerPhase 1
32
HSP-130 + US-approved Neulasta + EU-approved NeulastaPfizerPhase 1
32
linezolid + vancomycinPfizerPhase 3
76
AnidulafunginPfizerPhase 1/2
40
Nivestim®PfizerPre-clinical
22
Antibacterial agent for the treatment of febrile neutropeniaPfizerPre-clinical
22
VoriconazolePfizerPhase 1/2
40
Filgrastim Hospira (US) + U.S.-approved Neupogen®PfizerPhase 1
32

Other Products from Mayne Pharma Group

Halobetasol Topical FoamApproved
77
Doxycycline Hyclate Delayed-Release 200 mgApproved
77
Slow release oral morphine (SROM) + MethadonePhase 3
69
Permethrin Cream, 5% + ElimitePhase 3
69
Ivermectin 0.5% Topical Application Lotion + Ivermectin 0.5% Topical Application Lotion [SKLICE] + Placebo 0% LotionPhase 3
69